 - Patients must have progressed following at least one line of standard systemic therapy and there must not be other approvedstandard therapy available that has been shown to prolong overall survival i.e. in a randomized trial against another standard treatment or by comparison to historical controls; patients who cannot receive other standard therapy that has been shown to prolonged survival due to medical issues will be eligible, if other eligibility criteria are met; OR 